ロード中...
Validation of an NGS mutation detection panel for melanoma
BACKGROUND: Knowledge of the genotype of melanoma is important to guide patient management. Identification of mutations in BRAF and c-KIT lead directly to targeted treatment, but it is also helpful to know if there are driver oncogene mutations in NRAS, GNAQ or GNA11 as these patients may benefit fr...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322598/ https://ncbi.nlm.nih.gov/pubmed/28228113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3149-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|